Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01320072 · ClinicalTrials.gov registry record
Diagnosis of Aspirin Hypersensitivity in Aspirin Exacerbated Respiratory Disease
A clinical trial, sponsored by Montefiore Medical Center.
- Terminated
- Registry status
- 29
- Enrollment target
NCT01320072 is a clinical trial that was terminated before completion, run by Montefiore Medical Center. The registered enrollment target is 29 participants.
The verdict
NCT01320072 was terminated before completion, sponsored by Montefiore Medical Center.
- TERMINATED
- Registry status
- 29 participants
- Enrollment target
Study Summary
To diagnose aspirin hypersensitivity in asthmatics by using and safe, low-dose aspirin oral challenge. Hypothesis 1: A low dose of oral ASA (20 or 40 mg) will induce significantly different concentrations of arachidonic acid metabolites in ASA-sensitive asthmatics as compared to ASA-tolerant asthmatics. Hypothesis 2: The low dose (20 or 40 mg) ASA challenge will be well tolerated by ASA-sensitive asthmatics.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 29 participants |
| Start Date | 2010-05 |
| Est. Completion | 2022-05-26 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01320072
The ClinicalTrials.gov registry entry for NCT01320072 describes a study currently listed as terminated, categorized as an unspecified phase. The registered enrollment target is 29 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Montefiore Medical Center, which has 345 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT01320072 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01320072 about?
NCT01320072 is a clinical study titled "Diagnosis of Aspirin Hypersensitivity in Aspirin Exacerbated Respiratory Disease". To diagnose aspirin hypersensitivity in asthmatics by using and safe, low-dose aspirin oral challenge. Hypothesis 1: A low dose of oral ASA (20 or 40 mg) will induce significantly different concentrations of arachidonic acid metabolites in ASA-sensitive asthmatics as compared to ASA-tolerant asthma...
What is the current status of trial NCT01320072?
This trial is currently terminated. The enrollment target is 29 participants. The study started on 2010-05. Estimated completion is 2022-05-26.
Who is sponsoring clinical trial NCT01320072?
This trial is sponsored by Montefiore Medical Center, which has 345 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.